Average Co-Inventor Count = 6.78
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ludwig Institute for Cancer Research Limited (9 from 525 patents)
2. Cornell Research Foundation Inc. (4 from 1,521 patents)
3. Memorial Sloan Kettering Cancer Center (3 from 559 patents)
4. Other (1 from 832,843 patents)
5. The New York Hospital-cornell Medical Center (1 from 2 patents)
10 patents:
1. 8071717 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
2. 7795409 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof
3. 7795379 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
4. 7622568 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
5. 7354992 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
6. 7314721 - Small cell lung cancer associated antigens and uses therefor
7. 7132507 - Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses
8. 6911529 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
9. 6774226 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
10. 6448073 - Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof